BioHealth News Archive
QIAGEN Partners With Mirati Therapeutics Inc. to Develop KRAS-G12C Companion Diagnostic for Non-Small Cell Lung Cancer (NSCLC) · BioBuzz
HILDEN, Germany & GERMANTOWN, Md.–(BUSINESS WIRE)– QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard:QIA) today announced a global collaboration with Mirati Therapeutics Inc. (NASDAQ:MRTX) to continue developing a tissue-based…
Read More
AURP Virtual BIO Health Caucus – Showcasing State Bio Economies – June 8, 2021 | 1:00 pm – 4:30 pm Eastern
The bio economy is booming across the U.S., and not just in Boston or San Francisco. States are witnessing a resurgence of life science…
Read More
BIO KOREA 2021 International Convention to Unlock the Secret of Future Technologies | Business | The Daily News
As one of the most important global bio-health conventions, BIO KOREA 2021 International Convention has garnered great attention from home and abroad. To facilitate…
Read More
MIMETAS Opens Phenotypic Screening Center
LEIDEN, the Netherlands, May 27, 2021 / B3C newswire / -- MIMETAS, the global leader in human-relevant organ-on-a-chip models, has just opened their Phenotypic…
Read More
Study upgrades one of the largest databases of neuronal types
A study led by researchers from the Institute Cajal of Spanish Research Council (CSIC) in Madrid, Spain in collaboration with the Bioengineering Department of…
Read More
Dr. Laurie E. Locascio, Vice President for Research at both the University of Maryland College Park and Baltimore, Joins Rich Bendis on a New Episode of BioTalk
Dr. Laurie E. Locascio, Vice President for Research at both the University of Maryland College Park and Baltimore, Visits BioTalk to Discuss Her Career,…
Read More
In Conversation: Montgomery County, Maryland Executive Marc Elrich · BioBuzz
Montgomery County (MOCO), Maryland, sits at the epicenter of biopharma growth, investment, and innovation that makes the BioHealth Capital Region (BHCR) one of the…
Read More
BioFactura Announces Initiation of Phase I Study of BFI-751, a Stelara® (ustekinumab) Biosimilar | Business Wire
FREDERICK, Md.--(BUSINESS WIRE)--BioFactura, a leading developer of high-value biosimilar and biodefense drugs using its patented StableFastTM platform, announces today the initiation of a pivotal…
Read More
NIH spinout raises millions to attack drug-resistant cancers with RNA. It has big plans. · BioBuzz
A local biotech has secured millions of dollars in new investments to take its RNA therapies for drug-resistant cancers to the clinic. Gaithersburg’s miRecule Inc. has…
Read More
miRecule Inc. closes $5.7 M to Create Breakthrough RNA Therapies for Cancer and Muscular Dystrophy
Gaithersburg, MD. (May ____ 2021) miRecule, Inc. (“miRecule”), an emerging biotech company focused on the development of cutting-edge RNA therapeutics, announced today it has…
Read More
NIH spinout fighting cancer with RNA therapeutics raises millions – Washington Business Journal
The startup is developing therapeutics for drug-resistant cancers — and applying its technology to other arenas, including Covid-19. Image: MiRecule CEO Anthony Saleh, shown…
Read More
Biohealth Innovation – SBIR Virtual Office Hours (BHI and MCEDC) (June 9)
Are you and early stage company with innovative biohealth technology? Have you considered non-dilutive funding to advance your technology? Learn more about whether or…
Read More
Biohealth Innovation – SBIR Virtual Office Hours (BHI and MCEDC) (June 9)
Are you and early stage company with innovative biohealth technology? Have you considered non-dilutive funding to advance your technology? Learn more about whether or…
Read More
RoosterBio Releases RoosterGEM™, Cell and Gene Therapy’s First Complete Transduction Medium
RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess systems for cell and gene therapy product…
Read More
BHI NIH Entrepreneur-In-Residence Job Opening
BioHealth Innovation, Inc. (BHI), is a Montgomery County innovation intermediary which translates market-relevant research into commercial success by bringing together management, funding, and markets.…
Read More